Arena Pharmaceuticals, Inc. (ARNA) Reports In-Line Q2 Loss of 16c/Share
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $3.26 million versus the consensus estimate of $3.35 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
